- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 333/34 - Sulfur atoms
Patent holdings for IPC class C07D 333/34
Total number of patents in this class: 285
10-year publication summary
|
19
|
12
|
19
|
19
|
16
|
18
|
20
|
12
|
14
|
2
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Novartis AG | 10327 |
15 |
| Allergan, Inc. | 2206 |
10 |
| The Johns Hopkins University | 5825 |
10 |
| Cardioxyl Pharmaceuticals, Inc. | 46 |
9 |
| The Provost, Fellows, Foundation Scholars, and The Other Members of Board, of The College of The Holy and Undivided Trinity of Queen Elizabeth, Near Dublin | 176 |
7 |
| The University of Queensland | 665 |
7 |
| Oxford Drug Design Limited | 10 |
7 |
| The Institute of Cancer Research: Royal Cancer Hospital | 180 |
5 |
| Baylor College of Medicine | 997 |
4 |
| Kancera AB | 29 |
4 |
| Tetraphase Pharmaceuticals, Inc. | 52 |
4 |
| Tokyo Ohka Kogyo Co., Ltd. | 1548 |
4 |
| IFM Tre, Inc. | 5 |
4 |
| Reata Pharmaceuticals Holdings, LLC | 49 |
4 |
| Sumitomo Chemical Company, Limited | 9055 |
3 |
| The Regents of the University of Michigan | 4918 |
3 |
| Sumitomo Seika Chemicals Co., Ltd. | 1041 |
3 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3268 |
3 |
| Zymeworks Inc. | 253 |
3 |
| Wyeth | 223 |
3 |
| Other owners | 173 |